Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Hodgkin Disease 1

Interventions

thymoglobulin 1satralizumab 1rhoA GTP-Binding Protein 1eculizumab 1Sugars 1Steroids 1Prednisone 1Methylprednisolone 1Mesna 1Immunoglobulins 1Hizentra 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Cyclophosphamide 1CK-2017357 1Bortezomib 1Amifampridine 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Myasthenia Gravis × rhoA GTP-Binding Protein × Clear all
NCT05218096 2025-01-09

Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis

Alexion Pharmaceuticals, Inc.

Phase 2 Terminated
70 enrolled 14 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡